This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Simon Law Firm PC Announces Class Action Settlement

ST. LOUIS, March 21, 2013 /PRNewswire/ -- A settlement has been reached in a class action lawsuit against GlaxoSmithKline.  The lawsuit alleges that Defendant GlaxoSmithKline falsely and deceptively marketed its Breathe Right Snore Relief throat spray. Defendant denies the allegations in this lawsuit and asserts it has not violated any laws. To avoid further litigation, the Parties have reached a class action settlement, which was preliminarily approved by the Circuit Court of St. Clair County, Illinois.

Under the terms of the settlement, you may be entitled to compensation if you purchased Defendant's Breathe Right Snore Relief throat spray in the State of Illinois from January 1, 2008 through the present.  Excluded from the class are Defendant and its officers, directors, shareholders, partners, and owners; the Court presiding over any motion to approve this Settlement Agreement; and those persons who timely and validly request exclusion from the Settlement Class.

What Does The Settlement Provide? Settlement Class Members may submit a properly completed Claim Form and be eligible to receive Voucher or card in the amount of up to $8.00 that can be used the same as cash at retail stores in Illinois that sell Defendant's products for the purchase of "Breathe Right Nasal Strips".

How Do You Submit A Claim? To qualify for payment, you must submit a claim form by May 21, 2013.  Claim forms can either be submitted online, at www.ThroatSpraySettlement.com, or can be obtained by calling 1-888-879-8974.

What Are Your Other Options? If you don't want to be legally bound by the settlement, you must exclude yourself ("opt-out") by May 21, 2013.  The detailed notice (available at www.ThroatSpraySettlement.com or by calling 1-888-879-8974 explains how to exclude yourself from the settlement.  If you exclude yourself, you will not get any settlement payment and you cannot object to the settlement.  You also will not be bound by the settlement and may be able to sue (or continue to sue) GlaxoSmithKline regarding the claims in this lawsuit.

If you're a class member, you may object to any part of the settlement you don't like, and the Court will consider your views.  You must submit any objection in writing and must provide evidence of your membership in the Class.  The procedures for submitting written objections are set out in the detailed notice (available at  www.ThroatSpraySettlement.com or by calling 1-888-879-8974).

The Court will hold a Final Fairness Hearing at 9:00 a.m. on June 24, 2013 in Belleville, Illinois.  At this hearing, the Court will consider whether the settlement is fair, reasonable and adequate, and whether to approve the class representatives' incentive award in the total amount of $2,000, and attorneys' fees and expenses in the amount of $50,000.  You may attend the hearing, and you may hire your own lawyer, but you are not required to do so.  If there are objections that have been submitted in writing in advance of the hearing, the Court will consider them.  The Court will listen to people who have made a prior written request to speak at the hearing. After the hearing, the Court will decide whether to approve the settlement.

What To Do If You Have Questions. This Notice is just a summary. Detailed notice, as well as the Settlement Agreement and some other documents filed in this lawsuit, can be found online at www.ThroatSpraySettlement.com.  You also may call or write to the Throat Spray Settlement Administrator at 1-888-879-8974 or PO Box 3614, Minneapolis, MN 55403-0614 for more information. 

QUESTIONS?  CALL 1-888-879-8974 or VISIT www.ThroatSpraySettlement.com

MEDIA: Ryan Keane, 314-241-2929

SOURCE Simon Law Firm PC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs